Sarepta Therapeutics (SRPT) Said to Price $300M at $59.75 - Feurstein
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Sarepta Therapeutics (NASDAQ: SRPT) offering 4-5x oversubscribed, offering $300 million at $59.75, Adam Feurstein tweets citing a source.
$SRPT 4-5x oversubscribed, offering increased to $300M @ $59.75, per source.— Adam Feuerstein (@adamfeuerstein) September 22, 2016
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sarepta Therapeutics (SRPT) Target of Cautious Article
- Facebook (FB) November weekly 140 calls active into Q3 and outlook
- SunEdison (SUNEQ) Shares Ramp to Session Highs
Create E-mail Alert Related CategoriesEquity Offerings, FDA, Momentum Movers, Trader Talk
Related EntitiesAdam Feuerstein
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!